Literature DB >> 8077659

Co-receptor (CD4/CD8) engagement enhances CD3-induced apoptosis in thymocytes. Implications for negative selection.

D J McConkey1, L Fosdick, L D'Adamio, M Jondal, S Orrenius.   

Abstract

Negative selection of self-reactive immature T cells is mediated by TCR engagement and is thought to occur via apoptosis (programmed cell death). The requirement for the co-receptors CD4 and CD8 in negative selection has been demonstrated, but the biochemical mechanisms underlying their involvement in this process remain undefined. Here we present evidence that co-receptor engagement dramatically enhances CD3-induced endonuclease activation and cell death characteristic of apoptosis in immature thymocytes. The responses are associated with increased tyrosine phosphorylation of a number of cellular substrates, including the gamma isoform of phospholipase C, and with increased association of tyrosine phosphoproteins, including the protein tyrosine kinase p56lck, with the TCR complex. Co-receptor engagement also potentiated CD3-mediated Ca2+ increases via a mechanism dependent upon tyrosine kinase activation. Sustained Ca2+ availability was found to be necessary for endonuclease activation and apoptosis to occur. We suggest that CD4 and CD8 may participate in negative selection by enhancing TCR/CD3-induced tyrosine kinase activation and sustained Ca2+ increases that lead to endonuclease activation and apoptosis in self-reactive CD4+ CD8+ thymocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077659

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Enhancement of CD3-mediated thymocyte apoptosis by the cross-linkage of heat-stable antigen.

Authors:  Y Hitsumoto; D S Song; M Okada; F Hamada; S Saheki; N Takeuchi
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

Review 2.  TCRαβ+ CD4-/CD8- "double negative" T cells in health and disease-implications for the kidney.

Authors:  Andrea M Newman-Rivera; Johanna T Kurzhagen; Hamid Rabb
Journal:  Kidney Int       Date:  2022-04-09       Impact factor: 18.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.